Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
Clinical trial NCT03530293 · TERMINATED
Trial details
- NCT number
- NCT03530293
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2019-07-16
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.